1. ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192). (5th November 2018) Authors: Zadeh, Gelareh; Lang, Frederick; Daras, Mariza; Cloughesy, Timothy; Colman, Howard; Ong, Shirley; Ramakrishna, Rohan; Vogelbaum, Michael; Groves, Morris; Nassiri, Farshad; Frederick, L Sue; Gammon, Karen; Fulling, Sheila; Rowland, Kari Anne; Mitchell, Erin; Ewald, Brett; Tufaro, Frank; Peterkin, ... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTIM-08. SAFETY, EFFICACY, AND SURVIVAL RESULTS FROM A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 FOLLOWED BY STANDARD OF CARE RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG). (12th November 2021) Authors: Pérez-Larraya, Jaime Gállego; Garcia-Moure, Marc; Patiño-García, Ana; González-Huarriz, Marisol; Van der Lugt, Jasper; Astigarraga, Itziar; García-Ariza, Miguel; López-Ibor, Blanca; Jones, Chris; Mackay, Alan; Diez-Valle, Ricardo; Fueyo, Juan; Gomez-Manzano, Candelaria; Dobbs, Jessica; Ewald, Bre... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192). (20th November 2020) Authors: Zadeh, Gelareh; Daras, Mariza; Cloughesy, Timothy F; Colman, Howard; Kumthekar, Priya U; Chen, Clark C; Aiken, Robert; Groves, Morris D; Ong, Shirley; Ramakrishna, Rohan; Vogelbaum, Michael A; Khagi, Simon; Kaley, Thomas; Melear, Jason M; Peereboom, David M; Rodriguez, Analiz; Yankelevich, Maxim;... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase IA/II, multicentre, open‐label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non‐Hodgkin or Hodgkin lymphoma. (13th November 2013) Authors: Fanale, Michelle; Assouline, Sarit; Kuruvilla, John; Solal‐Céligny, Philippe; Heo, Dae S.; Verhoef, Gregor; Corradini, Paolo; Abramson, Jeremy S.; Offner, Fritz; Engert, Andreas; Dyer, Martin J. S.; Carreon, Daniel; Ewald, Brett; Baeck, Johan; Younes, Anas; Freedman, Arnold S. Journal: British journal of haematology Issue: Volume 164:Number 2(2014:Jan.) Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗